Influence of divalent copper, manganese and zinc ions on fibril nucleation and elongation of the amyloid-like yeast prion determinant Sup35p-NM.
暂无分享,去创建一个
[1] Julian P. Whitelegge,et al. Initiation and elongation in fibrillation of ALS-linked superoxide dismutase , 2008, Proceedings of the National Academy of Sciences.
[2] F. Marken,et al. Manganese Binding to the Prion Protein* , 2008, Journal of Biological Chemistry.
[3] E. Kremmer,et al. Prion protein/protein interactions: fusion with yeast Sup35p‐NM modulates cytosolic PrP aggregation in mammalian cells , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] S. Lindquist,et al. Alternative assembly pathways of the amyloidogenic yeast prion determinant Sup35–NM , 2007, EMBO reports.
[5] S. Lindquist,et al. Probing the Role of PrP Repeats in Conformational Conversion and Amyloid Assembly of Chimeric Yeast Prions* , 2007, Journal of Biological Chemistry.
[6] P. Faller,et al. Zinc binding to amyloid-beta: isothermal titration calorimetry and Zn competition experiments with Zn sensors. , 2007, Biochemistry.
[7] E. Rizzarelli,et al. Copper(II) interaction with prion peptide fragments encompassing histidine residues within and outside the octarepeat domain: speciation, stability constants and binding details. , 2007, Chemistry.
[8] David R. Brown,et al. Dual polarisation interferometry analysis of copper binding to the prion protein: evidence for two folding states. , 2007, Biochimica et biophysica acta.
[9] Heather T. McFarlane,et al. Atomic structures of amyloid cross-β spines reveal varied steric zippers , 2007, Nature.
[10] Atanas V Koulov,et al. Functional amyloid--from bacteria to humans. , 2007, Trends in biochemical sciences.
[11] G. Millhauser. Copper and the prion protein: methods, structures, function, and disease. , 2007, Annual review of physical chemistry.
[12] W. Colón,et al. Effect of zinc, copper, and calcium on the structure and stability of serum amyloid A. , 2007, Biochemistry.
[13] J. H. Viles,et al. Empirical rules for rationalising visible circular dichroism of Cu2+ and Ni2+ histidine complexes: Applications to the prion protein , 2007, FEBS Letters.
[14] S. Hersch,et al. Mechanisms of Copper Ion Mediated Huntington's Disease Progression , 2007, PloS one.
[15] Bryan F. Shaw,et al. Binding of a single zinc ion to one subunit of copper-zinc superoxide dismutase apoprotein substantially influences the structure and stability of the entire homodimeric protein. , 2007, Journal of the American Chemical Society.
[16] A. Miranker,et al. Formation of a stable oligomer of beta-2 microglobulin requires only transient encounter with Cu(II). , 2007, Journal of molecular biology.
[17] C. Masters,et al. Concentration dependent Cu2+ induced aggregation and dityrosine formation of the Alzheimer's disease amyloid-beta peptide. , 2007, Biochemistry.
[18] J. Collinge,et al. Inhibition of proteinase K activity by copper(II) ions. , 2007, Biochemistry.
[19] R. Tycko,et al. Amyloid of the prion domain of Sup35p has an in-register parallel β-sheet structure , 2006, Proceedings of the National Academy of Sciences.
[20] J. Collinge,et al. Multiple forms of copper (II) co-ordination occur throughout the disordered N-terminal region of the prion protein at pH 7.4. , 2006, The Biochemical journal.
[21] J. Collinge,et al. A reassessment of copper(II) binding in the full-length prion protein. , 2006, The Biochemical journal.
[22] E. Walter,et al. The affinity of copper binding to the prion protein octarepeat domain: evidence for negative cooperativity. , 2006, Biochemistry.
[23] David R. Brown,et al. High affinity copper binding by stefin B (cystatin B) and its role in the inhibition of amyloid fibrillation , 2006, The FEBS journal.
[24] J. Grosclaude,et al. Cu(II) induces small-size aggregates with amyloid characteristics in two alleles of recombinant ovine prion proteins. , 2006, Biochimica et biophysica acta.
[25] C. Dobson,et al. Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.
[26] G. Multhaup,et al. Effect of copper and manganese on the de novo generation of protease-resistant prion protein in yeast cells. , 2006, Biochemistry.
[27] G. Forloni,et al. Aggregation/fibrillogenesis of recombinant human prion protein and Gerstmann-Sträussler-Scheinker disease peptides in the presence of metal ions. , 2006, Biochemistry.
[28] R. A. Scott,et al. Modulating amyloid self-assembly and fibril morphology with Zn(II). , 2006, Journal of the American Chemical Society.
[29] S. Supattapone,et al. Copper (II) ions potently inhibit purified PrPres amplification , 2006, Journal of neurochemistry.
[30] J. H. Viles,et al. Solution 1H NMR investigation of Zn2+ and Cd2+ binding to amyloid-beta peptide (Abeta) of Alzheimer's disease. , 2006, Biochimica et biophysica acta.
[31] David R. Brown,et al. High Affinity Binding between Copper and Full-length Prion Protein Identified by Two Different Techniques* , 2005, Journal of Biological Chemistry.
[32] S. Lindquist,et al. Structural insights into a yeast prion illuminate nucleation and strain diversity , 2005, Nature.
[33] Vladimir N. Uversky,et al. Forcing Nonamyloidogenic β-Synuclein To Fibrillate† , 2005 .
[34] T. Kawai,et al. Metal Ion-dependent Effects of Clioquinol on the Fibril Growth of an Amyloid β Peptide* , 2005, Journal of Biological Chemistry.
[35] O. Bocharova,et al. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils. , 2005, Biochemistry.
[36] C. Griesinger,et al. Structural characterization of copper(II) binding to alpha-synuclein: Insights into the bioinorganic chemistry of Parkinson's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[37] R. Rudolph,et al. Primary structure elements of spider dragline silks and their contribution to protein solubility. , 2004, Biochemistry.
[38] M. R. Nilsson. Techniques to study amyloid fibril formation in vitro. , 2004, Methods.
[39] W. Colón,et al. Structural basis of protein kinetic stability: resistance to sodium dodecyl sulfate suggests a central role for rigidity and a bias toward beta-sheet structure. , 2004, Biochemistry.
[40] A. Giese,et al. Effect of metal ions on de novo aggregation of full-length prion protein. , 2004, Biochemical and biophysical research communications.
[41] H. Karch,et al. Cellular prion protein acquires resistance to proteolytic degradation following copper ion binding , 2004, Biological chemistry.
[42] R. Bujdoso,et al. Copper induces increased beta-sheet content in the scrapie-susceptible ovine prion protein PrPVRQ compared with the resistant allelic variant PrPARR. , 2004, The Biochemical journal.
[43] V. Uversky,et al. Conformational constraints for amyloid fibrillation: the importance of being unfolded. , 2004, Biochimica et biophysica acta.
[44] M. Harding,et al. The architecture of metal coordination groups in proteins. , 2004, Acta crystallographica. Section D, Biological crystallography.
[45] J. H. Viles,et al. Copper binding to the amyloid-beta (Abeta) peptide associated with Alzheimer's disease: folding, coordination geometry, pH dependence, stoichiometry, and affinity of Abeta-(1-28): insights from a range of complementary spectroscopic techniques. , 2004, The Journal of biological chemistry.
[46] D. Winge,et al. Yeast Contain a Non-proteinaceous Pool of Copper in the Mitochondrial Matrix* , 2004, Journal of Biological Chemistry.
[47] F. Chiti,et al. Investigation of the effects of copper ions on protein aggregation using a model system , 2004, Cellular and Molecular Life Sciences CMLS.
[48] Roger Cooke,et al. Conformational variations in an infectious protein determine prion strain differences , 2004, Nature.
[49] Thomas Scheibel,et al. The elongation of yeast prion fibers involves separable steps of association and conversion. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[50] T. Ben-Hur,et al. Copper binding to PrPC may inhibit prion disease propagation , 2003, Brain Research.
[51] George Perry,et al. Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. , 2003, Biochemistry.
[52] J. H. Viles,et al. Copper Binding to the Octarepeats of the Prion Protein , 2003, The Journal of Biological Chemistry.
[53] S. Lindquist,et al. Changes in the middle region of Sup35 profoundly alter the nature of epigenetic inheritance for the yeast prion [PSI+] , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[54] D. M. Morgan,et al. Metal switch for amyloid formation: insight into the structure of the nucleus. , 2002, Journal of the American Chemical Society.
[55] A. Miranker,et al. Formation of a copper specific binding site in non-native states of beta-2-microglobulin. , 2002, Biochemistry.
[56] V. Uversky,et al. Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. , 2001, The Journal of biological chemistry.
[57] S. Lindquist,et al. The role of conformational flexibility in prion propagation and maintenance for Sup35p , 2001, Nature Structural Biology.
[58] A. Bush,et al. Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126. , 2001, Biochemistry.
[59] S. Prusiner,et al. Copper-catalyzed oxidation of the recombinant SHa(29–231) prion protein , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[60] S. Hornemann,et al. Prion Protein Binds Copper within the Physiological Concentration Range* , 2001, The Journal of Biological Chemistry.
[61] D. Harris,et al. Copper Converts the Cellular Prion Protein into a Protease-resistant Species That Is Distinct from the Scrapie Isoform* , 2001, The Journal of Biological Chemistry.
[62] F. Cohen,et al. Identification of the Cu2+ binding sites in the N-terminal domain of the prion protein by EPR and CD spectroscopy. , 2000, Biochemistry.
[63] S. Lindquist,et al. Nucleated conformational conversion and the replication of conformational information by a prion determinant. , 2000, Science.
[64] D. Westaway,et al. Copper(II)-induced Conformational Changes and Protease Resistance in Recombinant and Cellular PrP , 2000, The Journal of Biological Chemistry.
[65] M. Hecht,et al. Nature disfavors sequences of alternating polar and non-polar amino acids: implications for amyloidogenesis. , 2000, Journal of molecular biology.
[66] J Kim,et al. Copper(II)-induced self-oligomerization of alpha-synuclein. , 1999, The Biochemical journal.
[67] T. O’Halloran,et al. Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase. , 1999, Science.
[68] F. Cohen,et al. Copper binding to the prion protein: structural implications of four identical cooperative binding sites. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[69] Xudong Huang,et al. Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological Acidosis* , 1998, The Journal of Biological Chemistry.
[70] F. Cohen,et al. Prion protein selectively binds copper(II) ions. , 1998, Biochemistry.
[71] L. Serpell,et al. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. , 1997, Journal of molecular biology.
[72] C. Masters,et al. The Amyloid Precursor Protein of Alzheimer's Disease in the Reduction of Copper(II) to Copper(I) , 1996, Science.
[73] J. Lakey,et al. Copper binding to the N-terminal tandem repeat region of mammalian and avian prion protein: structural studies using synthetic peptides. , 1995, Biochemical and biophysical research communications.
[74] L Regan,et al. Protein design: novel metal-binding sites. , 1995, Trends in biochemical sciences.
[75] C. Masters,et al. Rapid induction of Alzheimer A beta amyloid formation by zinc. , 1994, Science.
[76] T. Scheibel. Amyloid formation of a yeast prion determinant , 2007, Journal of Molecular Neuroscience.
[77] D. Eliezer,et al. NMR mapping of copper binding sites in alpha-synuclein. , 2006, Biochimica et biophysica acta.
[78] J. Buchner,et al. Protein aggregation as a cause for disease. , 2006, Handbook of experimental pharmacology.
[79] M. Saraste,et al. FEBS Lett , 2000 .
[80] D. Williams,et al. The Biological Chemistry of the Elements , 1991 .